Form D · Pharmaceuticals
Inhibikase Therapeutics, Inc.
Atlanta, GA · CIK 0001750149
Offering snapshot reported Jun 4, 2024 · SEC filing
- Reported sold
- $0 Offering amount: $8M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 4, 2024 | Initial | $0 | No comparison | 1 | SEC filing |
| Feb 7, 2023 | Initial | $4,200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $340K
- Finders' fees
- $0
- Form D file number
- 021-515107
Reflects proceeds from the sale of 4,761,904 warrants, each to purchase 1 share of common stock, with an exercise price per share of $1.68, if all such warrants were exercised.
Amount paid in connection with this offering of warrants and a concurrent offering of common stock, consisting of a $182,625.53 placement agent fee and expenses of $80,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group LLC | 120708 |
Source: Form D, filed Jun 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dennis Berman | Director |
| Gisele Dion | Director |
| Joseph Frattaroli, C.P.A. | Executive |
| Roy Freeman | Director |
| Roy Freeman M.D. | Director |
| Paul Grint | Director |
| Paul Grint, M.D. | Director |
| Garth Lees Rolfe | Executive |
| Milton H. Werner | Director, Executive |
| Milton H. Werner Ph.D | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3350 Riverwood Parkway Se, Suite 1900
Atlanta, GA, 30339
Atlanta, GA, 30339